Merus NV MCLA-129 Call Transcript
Thank you for standing by, and welcome to the Merus investor call. (Operator Instructions) I would now like to turn the conference over to Kathleen Farren, investor relations and corporate communications. Ms. Farren, please go ahead.
Good afternoon from Barcelona. Thank you for joining our call and for joining so early for those of you in the U.S. The purpose of this call is to discuss the data presented in the poster session of this year's EORTC-NCI-AACR meeting, which we also refer to as the triple meeting. The slide presentation is available on our website at www.merus.nl.
On this call, we will be making certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These may include statements about our future expectations and plans and events and circumstances, including about finances, intellectual property, projections about Merus' clinical development for 2022
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |